Cargando…

Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes

Protocols for clinical trials describe inclusion and exclusion criteria based on general and compound‐specific considerations to ensure subject safety and data quality. In phase I clinical trials, healthy volunteers (HVs) are screened against these criteria that often specify predefined eligibility...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deiteren, Annemie, Coenen, Erwin, Lenders, Sabine, Verwilst, Peter, Mannaert, Erik, Rasschaert, Freya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604224/ https://www.ncbi.nlm.nih.gov/pubmed/34378856 http://dx.doi.org/10.1111/cts.13113

Ejemplares similares

Incidental findings in UK healthy volunteers screened for a COVID‐19 vaccine trial
por: Hodgson, Susanne H., et al.
Publicado: (2021)

Healthy Beliefs regarding Breast Cancer Screening in Iranian Women Health Volunteers: A Path Analysis
por: Salmani, Fatemeh, et al.
Publicado: (2021)

Serial Participation and the Ethics of Phase 1 Healthy Volunteer Research
por: Walker, Rebecca L, et al.
Publicado: (2018)

Machine intelligence-driven framework for optimized hit selection in virtual screening
por: Kumar, Neeraj, et al.
Publicado: (2022)

Stability, reliability, and validity of the THINC‐it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers
por: Harrison, John E., et al.
Publicado: (2018)

In Vitro Effects of Sulforaphane on Interferon-Driven Inflammation and Exploratory Evaluation in Two Healthy Volunteers
por: Genova, Elena, et al.
Publicado: (2021)

Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development
por: Ahmed, Mariam A., et al.
Publicado: (2019)

Attitudes of healthy volunteers to genetic testing in phase 1 clinical trials
por: Levesque, Sebastian, et al.
Publicado: (2021)

Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency
por: van Staveren, Maurice C., et al.
Publicado: (2011)

Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization
por: Cao, G, et al.
Publicado: (2013)

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
por: Radanovic, Igor, et al.
Publicado: (2022)

Bayesian optimization-driven parallel-screening of multiple parameters for the flow synthesis of biaryl compounds
por: Kondo, Masaru, et al.
Publicado: (2022)

Volunteer effect and compromised randomization in the Mayo Project of screening for lung cancer
por: Dominioni, Lorenzo, et al.
Publicado: (2010)

Paediatric vision screening by non-healthcare volunteers: evidence based practices
por: Sabri, K., et al.
Publicado: (2019)

Inter-subject variability of pleasant pain relief using a data-driven approach in healthy volunteers
por: Henri, Catherine, et al.
Publicado: (2022)

Phase 1 safety trial of a natural product cocktail with antibacterial activity in human volunteers
por: Bruce, Julie, et al.
Publicado: (2022)

No antidepressant-like acute effects of bright light on emotional information processing in healthy volunteers
por: Kaltenboeck, Alexander, et al.
Publicado: (2021)

Optimizing Screening for HIV
por: Chaillon, Antoine, et al.
Publicado: (2020)

Morphological abnormalities in baseline ECGs in healthy normal volunteers participating in phase I studies
por: Hingorani, Pooja, et al.
Publicado: (2012)

Phase I clinical trials of anticancer drugs in healthy volunteers: Need for critical consideration
por: Gupta, Pooja, et al.
Publicado: (2012)

Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
por: Al‐Karagholi, Mohammad Al‐Mahdi, et al.
Publicado: (2021)

Clopidogrel, a CYP2C8 inhibitor, causes a clinically relevant increase in the systemic exposure to the active metabolite of selexipag in healthy subjects
por: Axelsen, Lene Nygaard, et al.
Publicado: (2020)

Safety, Tolerability, and Pharmacokinetics of JNJ-1802, a Pan-serotype Dengue Direct Antiviral Small Molecule, in a Phase 1, Double-Blind, Randomized, Dose-Escalation Study in Healthy Volunteers
por: Ackaert, Oliver, et al.
Publicado: (2023)

Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studies
por: Emanuel, Ezekiel J, et al.
Publicado: (2015)

Observations on Vamana procedure in healthy volunteers
por: Gupta, Bharti, et al.
Publicado: (2011)

Pharmacokinetics of Oral Taurine in Healthy Volunteers
por: Ghandforoush-Sattari, Mohammadreza, et al.
Publicado: (2010)

Prediction of Psilocybin Response in Healthy Volunteers
por: Studerus, Erich, et al.
Publicado: (2012)

Prediction of pain sensitivity in healthy volunteers
por: Ravn, Pernille, et al.
Publicado: (2012)

Pharmacokinetics of chloroquine and primaquine in healthy volunteers
por: Daher, André, et al.
Publicado: (2022)

Variability of microcirculatory measurements in healthy volunteers
por: Bol, M. E., et al.
Publicado: (2022)

Pharmacokinetics of intranasal amiloride in healthy volunteers
por: Yellepeddi, Venkata K., et al.
Publicado: (2023)

Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study
por: Smith, William B, et al.
Publicado: (2012)

Healthy Volunteer 2020: Comparing Peace Corps Volunteers' health metrics with Healthy People 2020 national objectives()
por: Henderson, Susan J., et al.
Publicado: (2016)

An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy Volunteers
por: Martens, Marieke Annie Gerdine, et al.
Publicado: (2021)

Machine-driven parameter screen of biochemical reactions
por: Poulain, Stéphane, et al.
Publicado: (2020)

Toward hypothesis-driven, personalized microbiome screening
por: Sedrani, Catherine, et al.
Publicado: (2022)

A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers
por: Attie, Kenneth M, et al.
Publicado: (2014)

Topical administration of regorafenib eye drops: phase I dose‐escalation study in healthy volunteers
por: Zimmermann, Torsten, et al.
Publicado: (2018)

Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers
por: Chandorkar, Gurudatt, et al.
Publicado: (2017)

A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers
por: Johansson, Susanne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ke347k1hiuofkrssesgbti5uh5